Research reveals prevention and early antiviral treatment improve outcomes in older adults, suggesting better management practices.
Older adults (aged ≥ 65 years) are at high risk of hospitalisation or death due to influenza. Guidance for the management of influenza in older adults is extremely limited, highlighting a global gap in current clinical understanding. Consensus is that prevention is key for older adults, via vaccination or non-pharmacological interventions. Antivirals should be initiated as soon as possible for patients with severe influenza or high-risk individuals, including older adults. Immunomodulatory therapies are under investigation for the treatment of influenza, but have had little success.
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: